Larsson O - Search Results

1

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.

Trautmann M, Sievers E, Aretz S, Kindler D, Michels S, Friedrichs N, Renner M, Kirfel J, Steiner S, Huss S, Koch A, Penzel R, Larsson O, Kawai A, Tanaka S, Sonobe H, Waha A, Schirmacher P, Mechtersheimer G, Wardelmann E, Büttner R, Hartmann W. Trautmann M, et al. Among authors: larsson o. Oncogene. 2014 Oct 16;33(42):5006-16. doi: 10.1038/onc.2013.443. Epub 2013 Oct 28. Oncogene. 2014. PMID: 24166495

2

Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype.

Xie Y, Skytting B, Nilsson G, Brodin B, Larsson O. Xie Y, et al. Among authors: larsson o. Cancer Res. 1999 Aug 1;59(15):3588-91. Cancer Res. 1999. PMID: 10446966

3

A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.

Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson O. Girnita L, et al. Among authors: larsson o. Oncogene. 2000 Aug 31;19(37):4298-301. doi: 10.1038/sj.onc.1203755. Oncogene. 2000. PMID: 10980604

4

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O. Ladanyi M, et al. Among authors: larsson o. Cancer Res. 2002 Jan 1;62(1):135-40. Cancer Res. 2002. PMID: 11782370

5

Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.

Yang K, Lui WO, Xie Y, Zhang A, Skytting B, Mandahl N, Larsson C, Larsson O. Yang K, et al. Among authors: larsson c, larsson o. Oncogene. 2002 Jun 13;21(26):4181-90. doi: 10.1038/sj.onc.1205569. Oncogene. 2002. PMID: 12037676

6

A novel type of SYT/SSX fusion: methodological and biological implications.

Törnkvist M, Brodin B, Bartolazzi A, Larsson O. Törnkvist M, et al. Among authors: larsson o. Mod Pathol. 2002 Jun;15(6):679-85. doi: 10.1038/modpathol.3880587. Mod Pathol. 2002. PMID: 12065783

7

SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.

Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, Brodin B, Mandahl N, Larsson O. Xie Y, et al. Among authors: larsson o. Cancer Res. 2002 Jul 1;62(13):3861-7. Cancer Res. 2002. PMID: 12097301

8

The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.

Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, Fisher C, Shipley J, Bjerkehagen B, Myklebost O, Larsson O. Xie Y, et al. Among authors: larsson o. Oncogene. 2002 Aug 22;21(37):5791-6. doi: 10.1038/sj.onc.1205700. Oncogene. 2002. PMID: 12173050

9

Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas.

Wei Y, Sun M, Nilsson G, Dwight T, Xie Y, Wang J, Hou Y, Larsson O, Larsson C, Zhu X. Wei Y, et al. Among authors: larsson c, larsson o. Oncogene. 2003 Apr 10;22(14):2215-22. doi: 10.1038/sj.onc.1206343. Oncogene. 2003. PMID: 12687023

10

Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene.

Xie Y, Törnkvist M, Aalto Y, Nilsson G, Girnita L, Nagy B, Knuutila S, Larsson O. Xie Y, et al. Among authors: larsson o. Oncogene. 2003 Oct 23;22(48):7628-31. doi: 10.1038/sj.onc.1207153. Oncogene. 2003. PMID: 14576825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters